课题基金 / 基金详情

项目摘要

项目成果

Jose Francisco Huizar的其他基金

相关文献

中文摘要
翻译
背景频繁的室性早搏(PVC)可导致LV功能障碍(CM), 称为PVC心肌病(PVC-CM)。PVC偶联间隔的影响及机理 (早产儿)不清楚。可疑的触发因素是期外收缩后增强和LV不同步。 假设。我们的四个工作假设是:1)与PVC相关的期外收缩后增强,是一种 负责PVC-CM的关键触发器。LV功能障碍(目的1)、EC偶联受损和二分体重构(目的 2)早-而不是晚-耦合PVC更大,因为这种现象在早- 而不是晚偶联的PVC; 2)PVC-CM中EC偶联受损是由于JPH-2和Cav1.2的变化。 二分体、JPH-2和Cav1.2通路的早期变化先于CM的发展 以及PVC停止后LV功能的恢复,提供证据表明这些变化是主要的 CM的原因(目的2);和4)基线临床和结构/分子表型可以识别这些动物 当暴露于33%的PVC负荷时,将形成PVC-CM。 目标1.评价期外收缩后增强和PVC偶联间期在以下发展中的影响 与慢性暴露于频繁PVC(PVC-CM)相关的LV功能障碍。 目标2.确定导致Ca2+释放减少的时间结构和分子变化, Junctophylin-2及其在PVC-CM病理生理学和PVC停止后恢复中的作用。 目标3.确定基线超声心动图、血流动力学和分子特征, 尽管有相同的心室异位,但仍发生或恢复PVC-CM。 方法. 56只动物将接受起搏器植入术,以重现频繁的心室异位(PVC)。他们 将被随机分配至4组之一:1)早期偶联50% PVC(n = 13),2)晚期偶联50% PVC(n = 13), 3)早期偶联PVC 33%PVC(n = 18),或4)对照组(n = 12)。在12周PVC期结束时, 将允许暴露于50%负荷和假手术的每组6只动物进入恢复期(致残性PVC) 组(图6)。连续心脏评估和活检将使我们能够评估LV功能,二分体结构,Ca2 + 瞬变(EC偶联),JPH-2和Cav1.2表达、功能和分布的变化及其 所有组在基线和PVC-CM的不同时间点的介质。 意义本研究将:1)提供对期外收缩后增强和LV PVC-CM机制中的不同步性; 2)评估PVC偶联间期在发育中的影响 3)确定PVC-CM中EC偶联受损背后的分子机制,以及4) 确定基线临床和分子表型,以区分有发生PVC-CM风险的患者。 了解PVC-CM的机制将有助于我们识别发生PVC的高危患者, CM,但最重要的是找到预防和治疗PVC-CM受试者的未来目标。
英文摘要
Background. Frequent premature ventricular contractions (PVCs) can cause LV dysfunction (CM), referred to as PVC-cardiomyopathy (PVC-CM). The mechanism responsible and the impact of PVC coupling interval (prematurity) are unclear. Suspected triggers are post-extrasystolic potentiation and LV dyssynchrony. Hypotheses. Our four working hypotheses are: 1) Post-extrasystolic potentiation, associated with PVCs, is a key trigger responsible for PVC-CM. LV dysfunction (Aim 1), impaired EC coupling and dyad remodeling (Aim 2) are greater in early- rather than late-coupled PVCs since this phenomenon is more prominent in early- rather than late-coupled PVCs; 2) Impaired EC coupling in PVC-CM is due to changes in JPH-2 and Cav1.2 pathways (Fig.1); 3) Early changes in dyad, JPH-2 and Cav1.2 pathways precede the development of this CM and the recovery of LV function after PVC cessation, providing evidence that these changes are a primary cause of CM (Aim 2); and 4) Baseline clinical and structural / molecular phenotype can identify those animals that will develop PVC-CM when exposed to 33% PVC burden. Aim 1. Evaluate the impact of post-extrasystolic potentiation and PVC coupling interval in the development of LV dysfunction associated with chronic exposure to frequent PVCs (PVC-CM). Aim 2. Determine the temporal structural and molecular changes responsible for decrease in Ca2+ release and Junctophylin-2, and their role on the pathophysiology of PVC-CM and recovery upon PVC cessation. Aim 3. Identify baseline echocardiographic, hemodynamic and molecular features that can predict the development of, or resilience to PVC-CM despite identical ventricular ectopy. Methods. 56 animals will undergo pacemaker implant to reproduce frequent ventricular ectopy (PVCs). They will be randomized to one of 4 groups: 1) early-coupled 50% PVCs (n=13), 2) late-coupled 50% PVCs (n=13), 3) early-coupled PVCs 33% PVCs (n=18), or 4) control (n=12) groups. At the end of a 12-week PVC period, a recovery phase (disabling PVCs) will be allowed in 6 animals of each group exposed to 50% burden and sham group (Fig. 6). Serial cardiac evaluation and biopsies will allow us to assess LV function, dyad structure, Ca2+ transients (EC coupling), changes in JPH-2 and Cav1.2 expression, function and distribution and their mediators at baseline and different time points of PVC-CM in all groups. Significance. This study will: 1) provide an understanding of the role of post-extrasystolic potentiation and LV dyssynchrony in the mechanism of PVC-CM; 2) assess the impact of PVC coupling interval in the development or severity of PVC-CM, 3) identify molecular mechanisms behind impaired EC coupling in PVC-CM and 4) identify baseline clinical and molecular phenotypes that distinguish patients at risk to develop PVC-CM. Understanding the mechanism of PVC-CM will help us to identify high-risk patients for development of PVC- CM, but most importantly find future targets to prevent and treat subjects with PVC-CM.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.jacep.2020.08.028
发表时间: 2021-03
期刊: JACC-CLINICAL ELECTROPHYSIOLOGY
影响因子: 7
作者: [Huizar, Jose F., Fisher, Susan G., Ramsey, Frederick, V, Kaszala, Karoly, Tan, Alex Y., Moore, Hans, Koneru, Jayanthi N., Kron, Jordana, Padala, Santosh K., Ellenbogen, Kenneth A., Singh, Steven N.]
通讯作者: Singh, Steven N.
Left ventricular dyssynchrony as marker of early dysfunction in premature ventricular contraction-induced cardiomyopathy.
左心室异位障碍作为早期功能障碍的标志性,在室性过早收缩引起的心肌病中。
DOI: 10.3389/fcvm.2022.978341
发表时间: 2022
期刊: FRONTIERS IN CARDIOVASCULAR MEDICINE
影响因子: 3.6
作者: [Kowlgi, Gurukripa N., Tan, Alex Y., Kaszala, Karoly, Kontos, Michael C., Lozano, Pedro, Ellenbogen, Kenneth A., Huizar, Jose F.]
通讯作者: Huizar, Jose F.
DOI: 10.1016/j.hroo.2020.12.021
发表时间: 2021-03
期刊: Heart rhythm O2
影响因子: --
作者: [Torrado J, Kowlgi GN, Ramirez RJ, Balderas-Villalobos J, Jovin D, Parker C, Om E, Airapetov S, Kaszala K, Tan AY, Ellenbogen KA, Huizar JF]
通讯作者: Huizar JF
Research-Dedicated Magnetic Resonance Imaging at McGuire VA Medical Center
Validation of Premature Ventricular Contraction-induced Cardiomyopathy on a Swine Model
LV dyssynchrony and fibroblast activation in PVC-induced Cardiomyopathy
Novel in situ custom biodegradable drug-eluting stents for endovascular surgery